Related Experiment Videos
FDA perspective on peptide formulation and stability issues
1Office of New Drug Chemistry, Office of Pharmaceutical Science, Center for Drug Evaluation and Research, Food and Drug Administration, Parklawn Building, Room 14B-45 5600 Fishers Lane, Rockville, Maryland 20857, USA.
Journal of Pharmaceutical Sciences
|November 13, 1998
Summary
Novel peptide drug delivery systems aim to overcome the limitations of traditional daily injections. These advanced methods offer improved patient compliance through prolonged, targeted, or pulsatile drug action, with several FDA-approved options available.
Area of Science:
- Pharmaceutical Sciences
- Drug Delivery Systems
- Biotechnology
Background:
- Traditional peptide drug administration involves daily sterile injections, leading to patient discomfort and poor adherence.
- Patient non-compliance with injectable peptide therapeutics necessitates the development of alternative drug delivery strategies.
- Existing delivery methods present challenges in achieving prolonged, localized, or pulsatile therapeutic effects.
Purpose of the Study:
- To review novel peptide drug delivery systems designed to enhance patient compliance and therapeutic outcomes.
- To explore various advanced dosage forms for peptide drugs, including oral, nasal, and controlled-release injectables.
- To discuss the unique characteristics and regulatory considerations associated with these innovative delivery systems.
Main Methods:
- Literature review of recent advancements in peptide drug delivery technologies.
- Analysis of FDA-approved novel peptide drug formulations.
- Comparative assessment of different delivery routes (oral, nasal, injectable) and their properties.
Main Results:
- Several novel peptide drug delivery systems have been recently approved by the FDA.
- These systems offer alternatives to daily injections, improving patient convenience and compliance.
- Various approaches provide prolonged, localized, or pulsatile drug release profiles.
Conclusions:
- Innovative peptide drug delivery systems are crucial for improving therapeutic efficacy and patient acceptance.
- Oral, nasal, and long-acting injectable formulations represent significant advancements in peptide drug administration.
- Understanding the characteristics and regulatory landscape is key to the successful implementation of these novel systems.